Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caligiuri

Showing results (1011-1020 of 1,066) with videos related to

Pageof 107
Sort By:
Blood|August 9, 2013
Antagonistic activities of the immunomodulator and PP2A-activating drug FTY720 (Fingolimod, Gilenya) in Jak2-driven hematologic malignanciesJoshua J Oaks, Ramasamy Santhanam, Christopher J Walker, et al.
Blood|October 27, 2012
Lenalidomide-mediated enhanced translation of C/EBPα-p30 protein up-regulates expression of the antileukemic microRNA-181a in acute myeloid leukemiaChristopher J Hickey, Sebastian Schwind, Hanna S Radomska, et al.
Nature Communications|February 1, 2025
miR-142 deficit in T cells during blast crisis promotes chronic myeloid leukemia immune escapeFang Chen, Dandan Zhao, Yongfang Xu, et al.
Frontiers in Veterinary Science|July 5, 2022
Complex Feline Disease Mapping Using a Dense Genotyping ArrayIsabel Hernandez, Jessica J Hayward, Jeff A Brockman, et al.
Immunity|September 9, 2018
CD56 Expression Marks Human Group 2 Innate Lymphoid Cell Divergence from a Shared NK Cell and Group 3 Innate Lymphoid Cell Developmental PathwayLuxi Chen, Youssef Youssef, Cameron Robinson, et al.
Cancer Cell|November 17, 2012
Aberrant overexpression of IL-15 initiates large granular lymphocyte leukemia through chromosomal instability and DNA hypermethylationAnjali Mishra, Shujun Liu, Gregory H Sams, et al.
Journal of Medicinal Chemistry|July 18, 2013
Structure-based discovery of novel amide-containing nicotinamide phosphoribosyltransferase (nampt) inhibitorsXiaozhang Zheng, Paul Bauer, Timm Baumeister, et al.
Blood|April 25, 2012
miR-3151 interplays with its host gene BAALC and independently affects outcome of patients with cytogenetically normal acute myeloid leukemiaAnn-Kathrin Eisfeld, Guido Marcucci, Kati Maharry, et al.
Cancer Cell|April 14, 2010
Sp1/NFkappaB/HDAC/miR-29b regulatory network in KIT-driven myeloid leukemiaShujun Liu, Lai-Chu Wu, Jiuxia Pang, et al.
Blood|October 3, 2013
Eradicating acute myeloid leukemia in a Mll(PTD/wt):Flt3(ITD/wt) murine model: a path to novel therapeutic approaches for human diseaseKelsie M Bernot, John S Nemer, Ramasamy Santhanam, et al.
Pageof 107

Showing results (1011-1020 of 1,066) with videos related to

Sort By:
Pageof 107
Blood|August 9, 2013
Antagonistic activities of the immunomodulator and PP2A-activating drug FTY720 (Fingolimod, Gilenya) in Jak2-driven hematologic malignanciesJoshua J Oaks, Ramasamy Santhanam, Christopher J Walker, et al.
Blood|October 27, 2012
Lenalidomide-mediated enhanced translation of C/EBPα-p30 protein up-regulates expression of the antileukemic microRNA-181a in acute myeloid leukemiaChristopher J Hickey, Sebastian Schwind, Hanna S Radomska, et al.
Nature Communications|February 1, 2025
miR-142 deficit in T cells during blast crisis promotes chronic myeloid leukemia immune escapeFang Chen, Dandan Zhao, Yongfang Xu, et al.
Frontiers in Veterinary Science|July 5, 2022
Complex Feline Disease Mapping Using a Dense Genotyping ArrayIsabel Hernandez, Jessica J Hayward, Jeff A Brockman, et al.
Immunity|September 9, 2018
CD56 Expression Marks Human Group 2 Innate Lymphoid Cell Divergence from a Shared NK Cell and Group 3 Innate Lymphoid Cell Developmental PathwayLuxi Chen, Youssef Youssef, Cameron Robinson, et al.
Cancer Cell|November 17, 2012
Aberrant overexpression of IL-15 initiates large granular lymphocyte leukemia through chromosomal instability and DNA hypermethylationAnjali Mishra, Shujun Liu, Gregory H Sams, et al.
Journal of Medicinal Chemistry|July 18, 2013
Structure-based discovery of novel amide-containing nicotinamide phosphoribosyltransferase (nampt) inhibitorsXiaozhang Zheng, Paul Bauer, Timm Baumeister, et al.
Blood|April 25, 2012
miR-3151 interplays with its host gene BAALC and independently affects outcome of patients with cytogenetically normal acute myeloid leukemiaAnn-Kathrin Eisfeld, Guido Marcucci, Kati Maharry, et al.
Cancer Cell|April 14, 2010
Sp1/NFkappaB/HDAC/miR-29b regulatory network in KIT-driven myeloid leukemiaShujun Liu, Lai-Chu Wu, Jiuxia Pang, et al.
Blood|October 3, 2013
Eradicating acute myeloid leukemia in a Mll(PTD/wt):Flt3(ITD/wt) murine model: a path to novel therapeutic approaches for human diseaseKelsie M Bernot, John S Nemer, Ramasamy Santhanam, et al.
Pageof 107